Delirium After Pregabalin Withdrawal

Pregabalin is a γ-amino butyric acid analogue drug that is used in fibromyalgia, neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury, and postherpetic neuralgia. Symptoms reported in association with pregabalin withdrawal include insomnia, gastrointestinal distress, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Çalışkan, Ali Metehan, İnanlı, İkbal, Çalışkan, Sıla, Eren, İbrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVES 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590627/
https://www.ncbi.nlm.nih.gov/pubmed/36425938
http://dx.doi.org/10.5455/apd.117770
_version_ 1784814529941602304
author Çalışkan, Ali Metehan
İnanlı, İkbal
Çalışkan, Sıla
Eren, İbrahim
author_facet Çalışkan, Ali Metehan
İnanlı, İkbal
Çalışkan, Sıla
Eren, İbrahim
author_sort Çalışkan, Ali Metehan
collection PubMed
description Pregabalin is a γ-amino butyric acid analogue drug that is used in fibromyalgia, neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury, and postherpetic neuralgia. Symptoms reported in association with pregabalin withdrawal include insomnia, gastrointestinal distress, tachycardia, and headache. This case report describes a 68-year-old patient who developed delirium after experiencing pregabalin withdrawal. Clinicians should be aware of the possibility of pregabalin withdrawal delirium.
format Online
Article
Text
id pubmed-9590627
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AVES
record_format MEDLINE/PubMed
spelling pubmed-95906272022-11-23 Delirium After Pregabalin Withdrawal Çalışkan, Ali Metehan İnanlı, İkbal Çalışkan, Sıla Eren, İbrahim Alpha Psychiatry Case Report Pregabalin is a γ-amino butyric acid analogue drug that is used in fibromyalgia, neuropathic pain associated with diabetic peripheral neuropathy, spinal cord injury, and postherpetic neuralgia. Symptoms reported in association with pregabalin withdrawal include insomnia, gastrointestinal distress, tachycardia, and headache. This case report describes a 68-year-old patient who developed delirium after experiencing pregabalin withdrawal. Clinicians should be aware of the possibility of pregabalin withdrawal delirium. AVES 2021-03-18 /pmc/articles/PMC9590627/ /pubmed/36425938 http://dx.doi.org/10.5455/apd.117770 Text en © Copyright 2021 authors https://creativecommons.org/licenses/by-nc/4.0/Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
spellingShingle Case Report
Çalışkan, Ali Metehan
İnanlı, İkbal
Çalışkan, Sıla
Eren, İbrahim
Delirium After Pregabalin Withdrawal
title Delirium After Pregabalin Withdrawal
title_full Delirium After Pregabalin Withdrawal
title_fullStr Delirium After Pregabalin Withdrawal
title_full_unstemmed Delirium After Pregabalin Withdrawal
title_short Delirium After Pregabalin Withdrawal
title_sort delirium after pregabalin withdrawal
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9590627/
https://www.ncbi.nlm.nih.gov/pubmed/36425938
http://dx.doi.org/10.5455/apd.117770
work_keys_str_mv AT calıskanalimetehan deliriumafterpregabalinwithdrawal
AT inanlıikbal deliriumafterpregabalinwithdrawal
AT calıskansıla deliriumafterpregabalinwithdrawal
AT erenibrahim deliriumafterpregabalinwithdrawal

Ejemplares similares